From today, argea.health describes both programmes in five languages: cancer therapy with the enzyme Argeon, one dose every 14 days for 24 weeks with a guarantee, and ARGEA Prevent, a six-dose course against 14 major solid tumours with ten years of coverage.
Enquiries are answered in writing within five working days. Physicians find comparative data, the monitoring protocol and the referral process in the clinicians' section.